Multi-mOdal Training program to promote physical actIVity After sTrokE (MOTIVATE): Protocol for a hybrid type 1 effectiveness-implementation randomised controlled trial

Authors:

Abstract
Background: Physical activity (PA) is a key modifiable behaviour for secondary prevention and recovery after stroke, yet effective and scalable PA interventions remain limited. MOTIVATE (Multi-mOdal Training program to promote physical actIVity After sTrokE) is a theory-informed, co-designed behaviour change intervention developed with stroke survivors, caregivers, and healthcare professionals to address these gaps.Aim: To determine whether MOTIVATE increases device-measured moderate-to-vigorous physical activity (MVPA) at 3 and 6 months among community-dwelling stroke survivors in Singapore, and to evaluate intervention fidelity, mechanisms of impact, and contextual factors relevant to future implementation and scale-up.Methods: MOTIVATE is a hybrid type 1 effectiveness–implementation, phase III randomized controlled trial with concealed allocation, assessor-blinded outcome measurement, and intention-to-treat analysis. Adults aged ≥21 years, ≥6 months post-stroke, living at home, and ambulant with or without an aid are eligible. Participants are randomized to MOTIVATE or education-alone care. Outcomes are assessed at baseline, 3 months, and 6 months, alongside process and economic evaluations. Recruitment of 120 participants provides 80% power to detect a 10-minute/day difference in MVPA, allowing for 20% attrition.Study outcomes: The primary outcome is average daily minutes of MVPA measured using Fitbit Inspire HR. Secondary outcomes include additional PA measures, physical function, participation, self-efficacy, fatigue, mood, sleep, quality of life, and health service utilisation. Outcomes will be analysed using Bayesian mixed-effects models.Discussion: MOTIVATE will provide new evidence on the effectiveness, implementation and cost-effectiveness of a co-designed, personalised behaviour change intervention to increase PA after stroke, supporting future scale-up in routine care.